Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,650,000 | -39.1% | 782,084 | -0.3% | 0.03% | -39.2% |
| Q4 2020 | $38,830,000 | +28.2% | 784,282 | -0.6% | 0.05% | +15.9% |
| Q3 2020 | $30,288,000 | -9.4% | 788,936 | +1.9% | 0.04% | -18.5% |
| Q2 2020 | $33,436,000 | +81.2% | 773,987 | +9.5% | 0.05% | +42.1% |
| Q1 2020 | $18,450,000 | +8.3% | 706,915 | +29.7% | 0.04% | +31.0% |
| Q4 2019 | $17,034,000 | – | 545,056 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |